CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?
20/5 09:43
Shares of gene therapy specialist, CRISPR Therapeutics (NASDAQ: CRSP) have been beaten down a long way despite some impressive accomplishments. The company already earned approval to sell its first treatment from the Food and Drug Administration (FDA), but the stock price is way...